We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Immunochemistry Analyzer Suitable for Low- to Mid-Volume Labs

By Labmedica staff writers
Posted on 22 Apr 2008
A new immunochemistry analyzer has been introduced, which was designed for labs that typically perform less than 200 immunoassay tests per day. More...
The instrument addresses many of the workflow challenges common in today's laboratories.

Called the Architect i1000SR analyzer, the new instrument enhances workflow and boosts laboratory productivity. Developed by Abbott (Abbott Park, IL, USA), the analyzer expands the Architect family of diagnostics instrument systems for clinical laboratories. The Architect i1000SR provides continuous access to reagents and samples while the instrument is running, enhancing laboratory productivity. Additionally, a wide test menu, user-friendly software, and low maintenance make it easy to train new laboratory personnel on the instrument's operation.

The Architect i1000SR analyzer can process up to 100 tests per hour. The instrument accommodates 65 patient samples and has the capability to prioritize emergency test results and turn them around in less than 16 minutes.

"Because time and ease of use are so critical in the testing environment, Abbott worked extensively with customers very early in the development phase and designed an instrument that could help smaller labs overcome the same productivity obstacles faced by larger labs,” said Cass Grandone, divisional vice president, Systems Development, Abbott Diagnostics. "The Architect i1000SR analyzer is ideal for facilities running less than 200 tests per day and offers productivity benefits, such as highly efficient sample processing, usually reserved for larger testing facilities. Since Architect utilizes common reagents, consumables, and software user interfaces, larger laboratories may be interested in using the instrument as a back-up system to the i2000SR.”

Similar to Architect ci8200 and ci16200, the analyzer is part of the Architect family, with important features including: family commonality, enhanced assay and system dynamics, and integration of immunoassay and clinical chemistry technologies without jeopardizing key performance, including turnaround time or accuracy of results.


Related Links:
Abbott

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.